Sat, Jul 12, 2014, 7:04 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cardica Inc. Message Board

  • fish_discover_water_last fish_discover_water_last Oct 7, 2013 10:13 PM Flag

    Question

    In an earlier presentation about their stapler plans they were touting a stapler that could be fired multiple times per deployment without being retracted and reinserted for staple reload. Does anyone know if they are still developing this technology and which product will include it?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • andersongordon@ymail.com andersongordon Oct 8, 2013 10:35 AM Flag

      In their latest investor presentation they have the XPress 30 as their fourth on the list of priorities:
      1) Get the XChange 30 thru the 510k process--coincident with this is the R&D work to show an expanded range of tissue that can be tolerated with the staples used by the EXchange 30. This will permit the XChange 30 to be used in vastly enhanced tissue surgeries for that increase of an addition 5 mm tolerance.
      2) Follow up with the development and regulatory approval of the XChange 45 and Xchange 60
      3) Follow up with the development and regulatory approval of the Flex 30
      4) Develop and get approval for the XPress 30
      The XPress 45 will be harder to accomplish because of the larger shaft required, its flexibility and technical challenges are significant. I don't think they will or have plans to try to develop the XPress 60 or the Flex 45 or Flex 60 for the same constraining reasons. Perhaps down the road once their marketing in the US is established and financial pressures are removed.

      GSA

    • Hi fish-

      Try searching on "cardica microcutter xpress 30"

      bb

      Sentiment: Buy

 
CRDC
1.150.00(0.00%)Jul 11 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.